Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2026-02-04 @ 8:00 AM
Study NCT ID:
NCT00003659
Status:
COMPLETED
Last Update Posted:
2017-10-24
First Post:
1999-11-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Leukemia | View |